| scholarly article | Q13442814 |
| P50 | author | Osamu Ohara | Q38155071 |
| Daisuke Tomizawa | Q41117632 | ||
| P2093 | author name string | Yoko Kuroki | |
| Leonard D Shultz | |||
| Takashi Watanabe | |||
| Masatoshi Takagi | |||
| Eiichi Ishii | |||
| Katsuyoshi Koh | |||
| Kaori Sato | |||
| Atsushi Hijikata | |||
| Fumihiko Ishikawa | |||
| Mariko Eguchi | |||
| Minenori Eguchi-Ishimae | |||
| Nahoko Suzuki | |||
| Yoriko Saito | |||
| Yuki Aoki | |||
| Rintaro Ono | |||
| Shuki Mizutani | |||
| Akiko Kaneko | |||
| Saera Fujiki | |||
| P2860 | cites work | Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1 | Q24316558 |
| Molecular regulation of H3K4 trimethylation by Wdr82, a component of human Set1/COMPASS | Q24320097 | ||
| A family of proteins that inhibit signalling through tyrosine kinase receptors | Q24336010 | ||
| Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine | Q24614582 | ||
| Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma | Q24631455 | ||
| The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors | Q24631515 | ||
| Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA | Q24632387 | ||
| A novel membrane glycoprotein, SHPS-1, that binds the SH2-domain-containing protein tyrosine phosphatase SHP-2 in response to mitogens and cell adhesion | Q24647689 | ||
| Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells | Q24657020 | ||
| Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice | Q24669724 | ||
| Prognostic relevance of integrated genetic profiling in acute myeloid leukemia | Q27851726 | ||
| TET2 mutations in acute myeloid leukemia (AML): results from a comprehensive genetic and clinical analysis of the AML study group | Q27851736 | ||
| Linear models and empirical bayes methods for assessing differential expression in microarray experiments | Q27860758 | ||
| hDOT1L links histone methylation to leukemogenesis | Q27935809 | ||
| Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47 | Q28138533 | ||
| The SIRP family of receptors and immune regulation | Q28239784 | ||
| Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice | Q28272701 | ||
| Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia | Q28273406 | ||
| Modeling the initiation and progression of human acute leukemia in mice | Q28299641 | ||
| Altered erythrocytes and a leaky block in B-cell development in CD24/HSA-deficient mice | Q28513057 | ||
| An Mll-dependent Hox program drives hematopoietic progenitor expansion | Q28588879 | ||
| Chimeric antigen receptor-modified T cells for acute lymphoid leukemia | Q29620130 | ||
| Construction of an open-access database that integrates cross-reference information from the transcriptome and proteome of immune cells | Q30483569 | ||
| c-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis | Q33604849 | ||
| MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele. | Q33694927 | ||
| Homeobox gene expression plus autocrine growth factor production elicits myeloid leukemia | Q33868950 | ||
| Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. | Q33887064 | ||
| Trithorax group proteins: switching genes on and keeping them active | Q34235226 | ||
| Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells | Q34416761 | ||
| Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells | Q34421127 | ||
| Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation. | Q35001583 | ||
| DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis | Q35083276 | ||
| Association between the polymorphism rs3217927 of CCND2 and the risk of childhood acute lymphoblastic leukemia in a Chinese population | Q35151947 | ||
| Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. | Q35606345 | ||
| MLL fusions: pathways to leukemia | Q35788362 | ||
| CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival. | Q35789342 | ||
| Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group | Q35848960 | ||
| Disruption of SIRPα signaling in macrophages eliminates human acute myeloid leukemia stem cells in xenografts | Q36278046 | ||
| Initiation of zebrafish haematopoiesis by the TATA-box-binding protein-related factor Trf3 | Q36293906 | ||
| In search of tumor suppressing functions of menin | Q36707655 | ||
| Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia | Q36793806 | ||
| Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation | Q36893499 | ||
| H3K79 methylation profiles define murine and human MLL-AF4 leukemias | Q36991857 | ||
| Menin critically links MLL proteins with LEDGF on cancer-associated target genes | Q37217351 | ||
| Anti-CD20 antibody therapy for B-cell lymphomas | Q38012522 | ||
| Failure of B-cell differentiation in mice lacking the transcription factor EBF. | Q38293381 | ||
| CD24 controls Src/STAT3 activity in human tumors. | Q39320370 | ||
| Histone post-translational modifications associated to BAALC expression in leukemic cells | Q39422718 | ||
| β-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells | Q39620290 | ||
| Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint | Q39659313 | ||
| CD9 correlates with cancer stem cell potentials in human B-acute lymphoblastic leukemia cells | Q39878019 | ||
| In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties | Q39965610 | ||
| Unique and independent roles for MLL in adult hematopoietic stem cells and progenitors | Q39997748 | ||
| CD24 expression is a new prognostic marker in breast cancer | Q40622453 | ||
| Signal-regulatory protein is selectively expressed by myeloid and neuronal cells. | Q41015014 | ||
| A reconfigured pattern of MLL occupancy within mitotic chromatin promotes rapid transcriptional reactivation following mitotic exit. | Q42060904 | ||
| Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia | Q42616476 | ||
| Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants | Q42643970 | ||
| Deletion of tetraspanin CD9 diminishes lymphangiogenesis in vivo and in vitro | Q42973720 | ||
| Definitive hematopoiesis requires the mixed-lineage leukemia gene | Q44805187 | ||
| SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes. | Q45944230 | ||
| Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5. | Q50876705 | ||
| Identification of Zfp521/ZNF521 as a cooperative gene for E2A-HLF to develop acute B-lineage leukemia. | Q51918384 | ||
| Outcome of risk-based therapy for infant acute lymphoblastic leukemia with or without an MLL gene rearrangement, with emphasis on late effects: a final report of two consecutive studies, MLL96 and MLL98, of the Japan Infant Leukemia Study Group. | Q51978470 | ||
| A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. | Q53232081 | ||
| Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. | Q53520724 | ||
| RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis | Q57016872 | ||
| Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia | Q59194346 | ||
| Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias | Q70905237 | ||
| International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy-related myelodysplastic syndromes and acute leukemia: overview report | Q77841177 | ||
| Age-related differences in leukemia biology and prognosis: the paradigm of MLL-AF4-positive acute lymphoblastic leukemia | Q79777401 | ||
| Characterization of acute lymphoblastic leukemia progenitor cells | Q80310211 | ||
| Landscape of TET2 mutations in acute myeloid leukemia | Q82675574 | ||
| P4510 | describes a project that uses | limma | Q112236343 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| lymphoblastic leukemia | Q18553852 | ||
| P304 | page(s) | 967-980 | |
| P577 | publication date | 2014-12-23 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Identification of CD34+ and CD34- leukemia-initiating cells in MLL-rearranged human acute lymphoblastic leukemia | |
| P478 | volume | 125 |
| Q47448562 | A non-cell-autonomous role for Pml in the maintenance of leukemia from the niche. |
| Q92090055 | Bafilomycin A1 targets patient-derived CD34+CD19+ leukemia stem cells |
| Q90782133 | CD9 blockade suppresses disease progression of high-risk pediatric B-cell precursor acute lymphoblastic leukemia and enhances chemosensitivity |
| Q49494161 | CD9 expression indicates a poor outcome in acute lymphoblastic leukemia |
| Q91738662 | Clinical-biological characteristics and treatment outcomes of pediatric pro-B ALL patients enrolled in BCH-2003 and CCLG-2008 protocol: a study of 121 Chinese children |
| Q39253931 | Dysregulation of haematopoietic stem cell regulatory programs in acute myeloid leukaemia |
| Q53010587 | Hematopoietic stem cells can be separated from leukemic cells in a subgroup of adult acute lymphoblastic leukemia patients. |
| Q91940332 | Identification and characterization of the cellular subclones that contribute to the pathogenesis of mantle cell lymphoma |
| Q92648102 | Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9 |
| Q58777025 | Investigating chemoresistance to improve sensitivity of childhood T-cell acute lymphoblastic leukemia to parthenolide |
| Q55484234 | Leukemia propagating cells in Philadelphia chromosome-positive ALL: a resistant phenotype with an adverse prognosis. |
| Q48218289 | Molecular processes involved in B cell acute lymphoblastic leukaemia. |
| Q30840810 | Plastic CD34 and CD38 expression in adult B-cell precursor acute lymphoblastic leukemia explains ambiguity of leukemia-initiating stem cell populations. |
| Q26783577 | Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia |
| Q26799954 | Stem Cell Hierarchy and Clonal Evolution in Acute Lymphoblastic Leukemia |
| Q98154733 | The RS4;11 cell line as a model for leukaemia with t(4;11)(q21;q23): Revised characterisation of cytogenetic features |
| Q37354907 | Transcriptional regulation of the proto-oncogene Zfp521 by SPI1 (PU.1) and HOXC13. |
| Q26770729 | ZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid Malignancies |
| Q64389640 | leukemia induction by t(9;11) chromosomal translocation in human hematopoietic stem cells using genome editing |
Search more.